{"id":658,"date":"2021-06-11T00:00:00","date_gmt":"2021-06-10T15:00:00","guid":{"rendered":"https:\/\/wwwt.kanazawa-med.ac.jp\/~ophthal\/?page_id=658"},"modified":"2021-06-11T00:00:00","modified_gmt":"2021-06-10T15:00:00","slug":"2021%e5%b9%b4%e5%ba%a6","status":"publish","type":"page","link":"https:\/\/ganka-kanazawamed.jp\/?page_id=658","title":{"rendered":"2021\u5e74\u5ea6"},"content":{"rendered":"\n

2021\u5e74\u5ea6<\/h2>\n\n\n\n

\u82f1\u6587\u539f\u8457<\/h4>\n\n\n
    \n
  1. Bhavana Chhunchha, Eri Kubo, Uday B. Kompella, Dhirendra P. Singh.
    Engineered Sumoylation-Deficient Prdx6 Mutant Protein-Loaded Nanoparticles Provide Increased Cellular Defense and Prevent Lens Opacity.
    Antioxidants (Basel). 2021: 10(8): 1245.<\/strong><\/li>\n
  2. Hiroshi Goto, Shun-Ichiro Ueda, Rei Nemoto, Koh-ichi Ohshima, Yuka Sogabe, Kazuko Kitagawa, Yoko Ogawa, Tokuhide Oyama, Minoru Furuta, Atsushi Azumi, Masayuki Takahira.
    Clinical features and symptoms of IgG4-related ophthalmic disease: a multicenter study.
    Japanese Journal of Ophthalmology. 2021: 65(5): 651-656.<\/strong><\/li>\n
  3. Ryoka Goto, Shigehiro Yamada, Hiroko Otake, Yosuke Nakazawa, Mikako Oka, Naoki Yamamoto, Hiroshi Sasaki, Noriaki Nagai.
    Instillation of Ophthalmic Formulation Containing Nilvadipine Nanocrystals Attenuates Lens Opacification in Shumiya Cataract Rats.
    Pharmaceutics. 2021: 13(12): 1999.<\/strong><\/li>\n
  4. Yusuke Gotoh, Teppei Yamaguchi, Hiroshi Yatsuya, Aki Ikeda, Takuya Okamura, Yosuke Sakakibara, Takuma Ina, Yuri Maeda, Mariko Hirochi, Hisashi Kako, Yasuhiro Goto, Sumito Isogai, Naoki Yamamoto, Masashi Kondo, Kazuyoshi Imaizumi.
    Predictive risk factors for pneumothorax after transbronchial biopsy using endobronchial ultrasonography with a guide sheath.
    BMC Pulmonary Medicine. 2021: 21(1): 181.<\/strong><\/li>\n
  5. Natsuko Hatsusaka, Yusuke Seki, Norihiro Mita, Yuki Ukai, Hisanori Miyashita, Eri Kubo, David Sliney, Hiroshi Sasaki.
    UV Index Does Not Predict Ocular Ultraviolet Exposure.
    Translational Vision Science & Technology. 2021: 10(7): 1.<\/strong><\/li>\n
  6. Natsuko Hatsusaka, Naoki Yamamoto, Hisanori Miyashita, Eri Shibuya, Norihiro Mita, Mai Yamazaki, Teppei Shibata, Hidetoshi Ishida, Yuki Ukai, Eri Kubo, Hong-Ming Cheng, Hiroshi Sasaki.
    Association among pterygium, cataracts, and cumulative ocular ultraviolet exposure: A cross-sectional study in Han people in China and Taiwan.
    PLoS One. 2021: 16(6): e0253093.<\/strong><\/li>\n
  7. Noriko Hiramatsu, Noriaki Nagai, Masashi Kondo, Kazuyoshi Imaizumi, Hiroshi Sasaki, Naoki Yamamoto.
    Morphological comparison between three-dimensional structure of immortalized human lens epithelial cells and Soemmering’s ring.
    Medical Molecular Morphology. 2021: 54(3): 216-226.<\/strong><\/li>\n
  8. Kazutaka Kamiya, Ken Hayashi, Mao Tanabe, Hitoshi Tabuchi, Masaki Sato, Norihito Gotoh, Takashi Kojima, Natsuko Hatsusaka, Data Analysis Committee of the Japanese Society of Cataract and Refractive Surgery.
    Nationwide multicentre comparison of preoperative biometry and predictability of cataract surgery in Japan.
    British Journal of Ophthalmology. 2021: 2021: 318825.<\/strong><\/li>\n
  9. Misa Minami, Hiroko Otake, Yosuke Nakazawa, Norio Okamoto, Naoki Yamamoto, Hiroshi Sasaki, Noriaki Nagai.
    Balance of Drug Residence and Diffusion in Lacrimal Fluid Determine Ocular Bioavailability in In Situ Gels Incorporating Tranilast Nanoparticles.
    Pharmaceutics. 2021: 13(9): 1425.<\/strong><\/li>\n
  10. Maya Mizuno, Hideaki Kitahara, Kensuke Sasaki, Masahiko Tani, Masami Kojima, Yukihisa Suzuki, Takafumi Tasaki, Yoshinori Tatematsu, Masafumi Fukunari, Kanako Wake.
    Dielectric property measurements of corneal tissues for computational dosimetry of the eye in terahertz band in vivo and in vitro.
    Biomedical Optics Express. 2021: 12(3): 1295-1307.<\/strong><\/li>\n
  11. Hiroko Otake, Mizuki Yamaguchi, Fumihiko Ogata, Saori Deguchi, Naoki Yamamoto, Hiroshi Sasaki, Naohito Kawasaki, Noriaki Nagai.
    Transdermal System Based on Solid Cilostazol Nanoparticles Attenuates Ischemia\/Reperfusion-Induced Brain Injury in Mice.
    Nanomaterials. 2021: 11(4): 1009.<\/strong><\/li>\n
  12. Hiroko Otake, Mizuki Yamaguchi, Fumihiko Ogata, Saori Deguchi, Naoki Yamamoto, Hiroshi Sasaki, Naohito Kawasaki, Noriaki Nagai.
    Energy-Dependent Endocytosis Is Responsible for Skin Penetration of Formulations Based on a Combination of Indomethacin Nanoparticles and L-Menthol in Rat and G\u00f6ttingen Minipig.
    International Journal of Molecular Sciences. 2021: 22(10): 5137.<\/strong><\/li>\n
  13. Shinsuke Shibata, Naoko Shibata, Satoshi Ohtsuka, Yasuo Yoshitomi, Etsuko Kiyokawa, Hideto Yonekura, Dhirendra P. Singh, Hiroshi Sasaki, Eri Kubo.
    Role of Decorin in Posterior Capsule Opacification and Eye Lens Development.
    Cells. 2021: 10(4): 863.<\/strong><\/li>\n
  14. Teppei Shibata, Masahito Ikawa, Ryo Sakasai, Yasuhito Ishigaki, Etsuko Kiyokawa, Kuniyoshi Iwabuchi, Dhirendra P. Singh, Hiroshi Sasaki, Eri Kubo.
    Lens\u2013specific conditional knockout of tropomyosin 1 gene in mice causes abnormal fiber differentiation and lens opacity.
    Mechanisms of Ageing and Development. 2021: 196: 111492.<\/strong><\/li>\n
  15. Nobuo Takeda, Masamichi Fukuda, Hiroshi Sasaki, Kazuhisa Sugiyama.
    The effects of antiglaucoma ophthalmic solutions on the cornea revealed by a corneal electrical resistance device.
    Journal of Ocular Pharmacology and Therapeutics. 2021: 37(2): 97-103.<\/strong><\/li>\n
  16. Yuki Ukai, Hajime Okemoto, Yusuke Seki, Yui Nakatsugawa, Akane Kawasaki, Teppei Shibata, Tsuyoshi Mito, Eri Kubo, Hiroshi Sasaki.
    Quantitative assessment of photic phenomena in the presbyopia-correcting intraocular lens.
    PLoS One. 2021: 16(12): e0260406.<\/strong><\/li>\n
  17. Naoki Yamamoto, Noriko Hiramatsu, Mahito Ohkuma, Natsuko Hatsusaka, Shun Takeda, Noriaki Nagai, Ei-ichi Miyachi, Masashi Kondo, Kazuyoshi Imaizumi, Masayuki Horiguchi, Eri Kubo, Hiroshi Sasaki.
    Novel Technique for Retinal Nerve Cell Regeneration with Electrophysiological Functions Using Human Iris-Derived iPS Cells.
    Cells. 2021: 10(4): 743.<\/strong><\/li>\n<\/ol>\n\n\n


    \u82f1\u6587\u305d\u306e\u4ed6<\/h4>\n\n\n
      \n
    1. Tsuyoshi Mito, Shun Takeda, Nozomu Motono, Hiroshi Sasaki.
      Atezolizumab-induced bilateral anterior uveitis: A case report.
      American Journal of Ophthalmology Case Reports. 2021: 24: 101205.<\/strong><\/li>\n<\/ol>\n\n\n


      \u90a6\u6587\u539f\u8457<\/h4>\n\n\n
        \n
      1. \u6c34\u6238\u6bc5, \u5c0f\u6797\u6b66\u53f2, \u767d\u77f3\u6566.
        \u7279\u96c6 \u7b2c74\u56de\u65e5\u672c\u81e8\u5e8a\u773c\u79d1\u5b66\u4f1a\u8b1b\u6f14\u96c6[2]\uff1a\u5f37\u819c\u5185\u56fa\u5b9a\u8853\u3067\u4f7f\u7528\u3059\u308b7.0mm\u30ec\u30f3\u30ba\u30686.0mm\u30ec\u30f3\u30ba\u306e\u81e8\u5e8a\u7d50\u679c\u306e\u6bd4\u8f03.
        \u81e8\u5e8a\u773c\u79d1. 2021: 75(4): 514-520.<\/strong><\/li>\n
      2. \u570b\u6b63\u831c, \u9ad9\u5c71\u7dbe\u5b50, \u9d5c\u98fc\u7950\u8f1d, \u6e0b\u8c37\u6075\u7406, \u5c71\u5d0e\u821e, \u67f4\u7530\u54f2\u5e73, \u67f4\u7530\u5948\u592e\u5b50, \u521d\u5742\u5948\u6d25\u5b50, \u5c71\u672c\u76f4\u6a39, \u4e45\u4fdd\u6c5f\u7406, \u4f50\u3005\u6728\u6d0b.
        3\u7126\u70b9\u773c\u5185\u30ec\u30f3\u30ba\u633f\u5165\u773c\u306e\u6b8b\u4f59\u4e71\u8996\u3068\u7126\u70b9\u6df1\u5ea6\u66f2\u7dda.
        \u65e5\u672c\u767d\u5185\u969c\u5b66\u4f1a\u8a8c. 2021: 33(1): 75-80.<\/strong><\/li>\n<\/ol>\n\n\n


        \u90a6\u6587\u305d\u306e\u4ed6<\/h4>\n\n\n
          \n
        1. \u4f50\u3005\u6728\u6d0b.
          \u3010\u7279\u96c6 \u7b2c74\u56de\u65e5\u672c\u81e8\u5e8a\u773c\u79d1\u5b66\u4f1a\u8b1b\u6f14\u96c6\uff3b1\uff3d\uff1a\u7279\u5225\u8b1b\u6f14\u3011\u767d\u5185\u969c\uff1a\u4e88\u9632\u3068\u6cbb\u7642\u3078\u306e\u65b0\u3057\u3044\u30a2\u30d7\u30ed\u30fc\u30c1.
          \u81e8\u5e8a\u773c\u79d1. 2021: 75(3): 287-301.<\/strong><\/li>\n
        2. \u5c71\u672c\u76f4\u6a39, \u4f50\u3005\u6728\u6d0b.
          \u3010\u7279\u96c6 \u623f\u6c34\u306e\u30b5\u30a4\u30a8\u30f3\u30b9\u30114. \u767d\u5185\u969c\u3068\u623f\u6c34.
          \u773c\u79d1. 2021: 63(11): 1059-1064.<\/strong><\/li>\n
        3. \u5c71\u5d0e\u821e.
          \u3010\u773c\u79d1\u624b\u8853Q&A\u3011V. \u767d\u5185\u969c\u3000Q1\u3000\u8996\u529b\u304c\u3088\u3044\u60a3\u8005\u306e\u767d\u5185\u969c\u624b\u8853\u9069\u5fdc\u3092\u6559\u3048\u3066\u304f\u3060\u3055\u3044.
          \u3042\u305f\u3089\u3057\u3044\u773c\u79d1. 2021: 38(\u81e8\u5897): 194-200.<\/strong><\/li>\n
        4. \u9d5c\u98fc\u7950\u8f1d.
          \u3010\u60a3\u8005\u6e80\u8db3\u5ea6\u3092\u9ad8\u3081\u308b!\u773c\u5185\u30ec\u30f3\u30ba\u95a2\u9023\u77e5\u8b58\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\u3011\u30b0\u30ec\u30a2\u30cf\u30ed\u30fc\u306e\u8a55\u4fa1.
          \u773c\u79d1\u30b0\u30e9\u30d5\u30a3\u30c3\u30af. 2021: 10(2): 195-201.<\/strong><\/li>\n
        5. \u4e45\u4fdd\u6c5f\u7406.
          \u3010\u6c34\u6676\u4f53\u7814\u7a76\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u3011\u85ac\u7269\u306b\u3088\u308b\u8001\u8996\u6cbb\u7642\u306e\u53ef\u80fd\u6027.
          \u65e5\u672c\u767d\u5185\u969c\u5b66\u4f1a\u8a8c. 2021: 33(1): 53-55.<\/strong><\/li>\n
        6. \u4e09\u7530\u54f2\u5927.
          \u3010\u308f\u304b\u308a\u3084\u3059\u3044\u81e8\u5e8a\u8b1b\u5ea7\u3011\u767d\u5185\u969c\u8a3a\u7642\u306b\u304a\u3051\u308b\u524d\u773c\u90e8\u89e3\u6790\u88c5\u7f6e\u306e\u6d3b\u7528.
          \u65e5\u672c\u306e\u773c\u79d1. 2021: 92(10): 14-18.<\/strong><\/li>\n
        7. \u6e0b\u8c37\u6075\u7406.
          \u3010\u78ba\u304b\u3081\u3088\u3046\uff01\u4e71\u8996\u306e\u57fa\u790e\u3000\u898b\u76f4\u305d\u3046\uff01\u4e71\u8996\u306e\u8a3a\u7642\u3011\u30c8\u30fc\u30ea\u30c3\u30af\u773c\u5185\u30ec\u30f3\u30ba\u306e\u8ef8\u30ba\u30ec\u3092\u8003\u3048\u308b.
          Monthly Book OCULISTA. 2021: 95: 49-59.<\/strong><\/li>\n
        8. \u5c71\u5d0e\u821e.
          \u3010\u81e8\u5e8a\u30bb\u30df\u30ca\u30fc\u3011\u773c\u5185\u30ec\u30f3\u30ba\u633f\u5165\u773c\u306e\u660e\u8996\u57df\u3068\u7126\u70b9\u6df1\u5ea6\u66f2\u7dda.
          IOL&RS. 2021: 35(4): 665-669.<\/strong><\/li>\n
        9. \u85e4\u672c\u53ef\u82b3\u5b50, \u4e2d\u6751\u53cb\u662d, \u5317\u6fa4\u4e16\u5fd7\u535a, \u4e45\u4fdd\u6c5f\u7406.
          \u30b3\u30f3\u30b5\u30eb\u30c6\u30fc\u30b7\u30e7\u30f3\u30b3\u30fc\u30ca\u30fc\u3000\u30a8\u30ad\u30b9\u30d1\u30fc\u30c8\u306b\u805e\u304f.
          IOL&RS. 2021: 35(4): 703-707.<\/strong><\/li>\n
        10. \u5c71\u672c\u76f4\u6a39, \u6b66\u7530\u5cfb, \u521d\u5742\u5948\u6d25\u5b50, \u5e73\u677e\u7bc4\u5b50, \u9577\u4e95\u7d00\u7ae0, \u51fa\u53e3\u7ca7\u592e\u91cc, \u4e2d\u6fa4\u6d0b\u4ecb, \u9ad8\u7530\u5320, \u5c0f\u5bfa\u7d17\u5343\u5b50, \u5e73\u7530\u6643\u6b63, \u4e45\u4fdd\u6c5f\u7406, \u4f50\u3005\u6728\u6d0b.
          \u3010\u5916\u56fd\u8a8c\u8981\u89a7\u3011\u65b0\u898f\u4e0d\u6b7b\u5316\u30d2\u30c8\u6c34\u6676\u4f53\u4e0a\u76ae\u7d30\u80de\u3092\u7528\u3044\u305f\u4f4e\u6e29\u57f9\u990a\u306b\u304a\u3051\u308b\u6c34\u6676\u4f53\u86cb\u767d\u8cea\u306e\u5f71\u97ff.
          \u65e5\u672c\u773c\u79d1\u5b66\u4f1a\u96d1\u8a8c. 2021: 125(4): 474.<\/strong><\/li>\n
        11. \u5c71\u672c\u76f4\u6a39, \u4e45\u4fdd\u6c5f\u7406, \u4f50\u3005\u6728\u6d0b.
          \u3010\u5916\u56fd\u8a8c\u8981\u89a7\u3011\u65b0\u898f\u4e0d\u6b7b\u5316\u30d2\u30c8\u6c34\u6676\u4f53\u4e0a\u76ae\u7d30\u80de\u682a\uff08iHLEC-NY2\uff09\u3092\u7528\u3044\u305f\u4f4e\u6e29\u57f9\u990a\u306b\u304a\u3051\u308b\u6c34\u6676\u4f53\u86cb\u767d\u8cea\u306e\u5f71\u97ff.
          \u65e5\u672c\u767d\u5185\u969c\u5b66\u4f1a\u8a8c. 2021: 33(1): 82.<\/strong><\/li>\n
        12. \u4f50\u3005\u6728\u6d0b.
          \u5dfb\u982d\u8a00.
          \u65e5\u672c\u767d\u5185\u969c\u5b66\u4f1a\u8a8c. 2021: 33(1): 1.<\/strong><\/li>\n
        13. \u5c71\u672c\u76f4\u6a39.
          \u6559\u5ba4\u7814\u7a76\u7d39\u4ecb\uff1a\u91d1\u6ca2\u533b\u79d1\u5927\u5b66\u773c\u79d1\u5b66\u8b1b\u5ea7.
          \u65e5\u672c\u767d\u5185\u969c\u5b66\u4f1a\u8a8c. 2021: 33(1): 89-91.<\/strong><\/li>\n
        14. \u6876\u672c\u5b5f.
          \u3053\u306e\u4eba\u306b\u6ce8\u76ee\u3000\u6700\u512a\u79c0\u5ea7\u9577\u8cde\u53d7\u8cde\u8005.
          IOL&RS. 2021: 35(4): 693-694.<\/strong><\/li>\n<\/ol>","protected":false},"excerpt":{"rendered":"

          2021\u5e74\u5ea6 \u82f1\u6587\u539f\u8457 Bhavana Chhunchha, Eri Kubo, Uday B. Kompella, Dhirendra P. Singh.Engineered Sumoylation-Deficient<\/p>\n